NEPHROPLUS
NSENephrocare Health Services Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Healthcare Service Provider
₹649.00
15.60 (2.46%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹6.51K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Healthcare Service Provider
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹446+45.5%
52W High₹769.75-15.7%
Current Price
₹649.00
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹519.20
Upper Circuit₹778.80
Reference Price
₹649.00
Investment Checklist
Ascending Channel on 1D — target ₹668.47
Volume divergence: Bullish (price down, volume up)
EMA(50) Crossover: Price crossed above EMA(50): Fresh bullish momentum signal.
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price below SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
46%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
669
EMA50
646.86
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows4
Lower Highs5
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹663.90
₹769.75
Support (Below)
₹648.10
₹616.00
₹598.92
₹541.95
₹519.25
Volume Analysis
TrendSTABLE
Change+3.30%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹642.51
3% Risk₹629.53
5% Risk₹616.55
7% Risk (Custom)
₹603.57Technical Levels
1x ATR (Volatility)₹618.70
2x ATR (Swing)₹588.40
3x ATR (Trend)₹558.10
Immediate Support₹648.10
Moving Averages
EMA 50 (Trend)₹646.86
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Dec '25 |
|---|---|---|---|
| Revenue | ₹197.3 Cr | ₹211.7 Cr | ₹259.7 Cr |
| Net Profit | ₹20.1 Cr | ₹24.9 Cr | ₹32.2 Cr |
| EPS | ₹2.00 | — | ₹3.43 |
| Operating Profit | ₹49.5 Cr | ₹53.4 Cr | ₹64.2 Cr |
ROE
11.49%
ROCE
12.63%
Debt/Equity
0.44
Current Ratio
1.92
OPM
24.71%
NPM
12.41%
Peer Comparison
Healthcare Service ProviderPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Dr. Lal Path Labs Ltd. | ₹1,692.80 | +0.49% | 55.4 | ₹28.36K Cr small Cap | |
| Vijaya Diagnostic Centre Limited | ₹1,389.10 | +0.82% | 82.0 | ₹14.29K Cr small Cap | |
| Thyrocare Technologies Limited | ₹515.70 | -3.71% | 52.8 | ₹8.21K Cr small Cap | |
| Nephrocare Health Services Limited | ₹649.00 | +2.46% | — | ₹6.51K Cr small Cap | |
| Metropolis Healthcare Limited | ₹567.95 | +1.41% | 60.7 | ₹2.94K Cr small Cap | |
| Krsnaa Diagnostics Limited | ₹556.65 | -0.04% | 17.8 | ₹1.81K Cr small Cap | |
| Suraksha Diagnostic Limited | ₹264.30 | +0.34% | 43.7 | ₹1.38K Cr small Cap | |
| Health X Platform Limited | ₹323.30 | -1.93% | 34.1 | ₹1.03K Cr small Cap | |
| 3B Blackbio Dx Limited | ₹1,148.60 | -1.64% | — | ₹986 Cr small Cap | |
| Chandan Healthcare Limited | ₹249.65 | -1.75% | 21.8 | ₹610 Cr small Cap | |
| Invicta Diagnostic Limited | ₹69.00 | -0.58% | — | ₹87 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for NEPHROPLUS
View All
positive
ET Markets - Industry 24d ago
Public-private projects key to expand access to Kidney care: NephroPlus
NephroPlus, India's leading provider of dialysis services, is on a mission to reshape the future of kidney health with an innovative tech-based platform aimed at preventing chronic kidney disease. As it scales up its network of dialysis centers both domestically and in global markets, this forward-thinking initiative seeks to combat the advancement of kidney ailments.
AGARWALEYEAMRUTANJANFELFELDVRGLOBALHEALTHXMEDANTANEPHROPLUSPGHHRPPINFRATECHZOTAZTECHConstructionConsumer Services
NEWS
positive
Business Standard - Markets 31d ago
NEPHROPLUS to acquire dialysis center assets in Paranaque City, Philippines
NEPHROPLUSHealthcare
NEWS
positive
Business Standard - Markets 35d ago
Nephrocare Health Services gains as arm acquires dialysis centre assets in Philippines
Nephrocare Health Services rose 1.32% to Rs 670 after its wholly owned subsidiary, Nephrocare Health Care Services Philippines Inc., has entered into an Asset Transfer Agreement with Inocentes Dialysis Clinic.
AGARWALEYEAMRUTANJANMEDANTANEPHROCARENEPHROPLUSPGHHZOTAFast Moving Consumer GoodsHealthcare